Lite Strategy LITS
NASDAQ LITS
$0.99 +0.05 (+4.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Change in Cash (2010 - 2026)

Lite Strategy (LITS) posted quarterly Change in Cash of -$1.2 million for Q1 2026, up 62.84% year-over-year from -$745514.7 in Q1 2025, and up 10.41% quarter-over-quarter from -$1.4 million in Q4 2025.

Lite Strategy (LITS) Change in Cash (2010 - 2026) Analysis & Trends

Lite Strategy's Change in Cash history runs 17 years deep, the most recent figure standing at -$1.2 million for Q1 2026.

  • In Q1 2026, Change in Cash rose 62.84% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at -$12.9 million (down 171.41% YoY), while the FY2025 annual figure was $14.3 million, up 208.37% from the prior year.
  • Change in Cash for Q1 2026 stood at -$1.2 million, up from -$1.4 million in the prior quarter.
  • The five-year high for Change in Cash was $16.8 million in Q4 2024, with the low at -$13.5 million in Q3 2023.
  • The 5-year median for Change in Cash is -$1.4 million (2025), against an average of -$294529.4.
  • The sharpest annual moves came in 2023 and 2024: Change in Cash tumbled 1145.08% in 2023, then soared 831.58% in 2024.
  • Lite Strategy's Change in Cash stood at -$3.7 million in 2022, then soared by 148.23% to $1.8 million in 2023, then jumped by 831.58% to $16.8 million in 2024, then plunged by 108.07% to -$1.4 million in 2025, then increased by 10.41% to -$1.2 million in 2026.
  • Business Quant data shows LITS's Change in Cash at -$1.2 million in Q1 2026, -$1.4 million in Q4 2025, and -$7.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -185.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 427.25 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -2.94 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -2.83 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -37.42 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 225.59 Mn
10 Lite Strategy 35.71 Mn 28.17 Mn - -1.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.21 Mn
Dec 31, 2025 -1.36 Mn
Sep 30, 2025 -7.90 Mn
Jun 30, 2025 -2.46 Mn
Mar 31, 2025 -3.27 Mn
Dec 31, 2024 16.79 Mn
Sep 30, 2024 3.25 Mn
Jun 30, 2024 1.34 Mn
Mar 31, 2024 -2.81 Mn
Dec 31, 2023 1.80 Mn
Sep 30, 2023 -13.53 Mn
Jun 30, 2023 8.09 Mn
Mar 31, 2023 -2.11 Mn
Dec 31, 2022 -3.74 Mn
Sep 30, 2022 -1.09 Mn
Jun 30, 2022 4.63 Mn
Mar 31, 2022 -1.44 Mn
Dec 31, 2021 -3.07 Mn
Sep 30, 2021 7.08 Mn
Jun 30, 2021 -1.20 Mn